北美翼状胬肉药物市场 – 行业趋势和 2029 年预测

北美翼状胬肉药物市场分析与洞察

翼状胬肉是一种常见的眼表病变，始于眼睑裂内的角膜缘，并进展至角膜。它以希腊语 pterygos 命名，意为“翅膀”。这种病变在鼻翼缘比颞侧更常见，具有典型的翼状外观。紫外线照射与翼状胬肉的发生密切相关。有高紫外线照射史和居住在赤道附近的人发病率较高（户外工作）。根据某些研究，男性发病率略高于女性，这可能是由于紫外线照射率较高。

它会导致眼睛发红、发炎和外观改变；它会导致散光，从而导致视力模糊；它还会导致白色或粉红色的肿块覆盖在眼睛前部。它可能影响一只眼睛或两只眼睛。

翼状胬肉的诊断是在全面眼科检查中使用显微镜检查眼睛的前部，并根据眼睛白色区域角膜上的组织生长情况进行。

Data Bridge Market Research 分析称，2022 年至 2029 年的预测期内，北美翼状胬肉药物市场将以 5.8% 的复合年增长率增长。

 North America Pterygium Drug Market Dynamics

Drivers

• Rise in incidences and prevalence of ophthalmic disorders

According to data published in the National Library of Medicine (National Center for Biotechnology Information) in 2021, the prevalence rates vary in different places. It is most abundant in Cameron's "pterygium belt," which runs between 37° north and south of the equator.

The most common causes of pterygium include long-term exposure to ultraviolet (UV) light from the sun (the most common cause) and eye irritation caused by hot, dry weather, wind, and dust. The affirmative factors state that this is the major driver for the North America pterygium drugs market.

• Rise in the geriatric population

With the growing geriatric population across the globe, the prevalence of ophthalmic diseases with severe ocular pain is also growing. According to data provided published in "Global Prevalence of Blindness and Distance and Near Vision Impairment in 2020: progress towards the Vision 2020 targets and what the future holds" by "The Association for Research in Vision and Ophthalmology" (ARVO) estimated 41.9 million people were blind.

With the growing population, the pressure on the healthcare system is increasing. The demand for care and services is rising to treat the problem of Ophthalmol disorder, including pterygium. Therefore, the increasing geriatric population is a great opportunity for the North America pterygium drug market.

Opportunities

• Programs and initiatives to reduce the burden of eye diseases

The International agency to prevent blindness has launched several programs and initiatives with well-reputed NGOs and corporates to spread awareness and reduce the burden of eye diseases.

For instance,

• International Agency endorses our Children's Vision and an initiative co-founded by the Brien Holden Vision Institute and the Vision For Life fund (created by Essilor) for the Prevention of Blindness (IAPB)

Restraints/Challenges

• High cost of eye treatment and medication

The growing prevalence of various ophthalmic disorders has also increased the necessity for timely treatments. However, the treatments and proper medication for ophthalmology disorders are not very cheap. Recent studies show that the price of topical steroids price is increasing in the past few years. Even though some topical ophthalmic steroids like prednisolone are mildly cheap, other advanced medications and eye drops are still expensive.

The North America pterygium drug market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pterygium drug market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed market decision to achieve market growth.

Patient Epidemiology Analysis

The prevalence of ophthalmic disorders keeps showing a surge in growth due to the rise in chemical industries and pollution worldwide. Chemical burns and flash burns cause significant and severe ocular pain due to irritations over the eye surface.

According to data published in the National Library of Medicine (National Center for Biotechnology Information) in 2021, the prevalence rates vary in different places. It is most abundant in Cameron's "pterygium belt," which runs between 37° north and south of the equator. Pterygium prevalence has been reported to range from 0.3 to 29% worldwide.

The North America pterygium drug market also provides detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, and adherence are some data variables available in the report. Direct or indirect impact analysis of epidemiology to the market growth are analyzed to create a more robust and cohot multivariate statistical model for forecasting the market in the growth period.

Post-COVID-19 Impact on North America Pterygium Drug Market

COVID-19 has negatively affected the market. Lockdowns and isolations during pandemics complicate disease management and medication adherence. The lack of access to healthcare facilities for routine treatment and medication administration will further impact the market.

Recent Development

• In January 2022, Alcon announced the launch of Systane complete preservative-free lubricant eye drops in Europe. The product works to provide all-in-one dry eye relief with one drop by hydrating the layers of the tear film. This has helped the company to increase its product portfolio

North America Pterygium Drug Market Scope

The North America pterygium drug market is categorized into eight notable segments based on disease type, stages, treatment, and formulation, mode of purchase, population type, end-user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disease Type

• Progressive Pterygium
• Atrophic Pterygium

根据疾病，北美翼状胬肉药物市场分为进行性翼状胬肉和萎缩性翼状胬肉。

阶段

• 第一阶段
• 第 2 阶段
• 第 3 阶段

根据分期，北美翼状胬肉药物市场分为 1 期、2 期、3 期、

治疗

• 人工泪液/外用润滑剂
• 类固醇眼药水

根据治疗方法，北美翼状胬肉药物市场分为人工泪液/外用润滑剂和类固醇眼药水。

配方

• 眼药水
• 眼药膏
• 其他的

根据配方，北美翼状胬肉药物市场分为眼药水、眼药膏和其他药物。

购买方式

• 处方
• 场外交易 (OTC)

根据购买方式，北美翼状胬肉药物市场分为处方药和非处方药（OTC）。

人口类型

• 老年
• 成年人

根据人口类型，北美翼状胬肉药物市场分为老年人和成年人。

终端用户

• 医院
• 专科诊所
• 家庭医疗保健
• 其他的

根据最终用户，北美翼状胬肉药物市场分为医院、专科诊所、家庭医疗保健和其他。

分销渠道

• 零售药店
• 医院药房
• 网上药店
• 其他的

根据分销渠道，北美翼状胬肉药物市场分为零售药店、医院药店和网上药店。

北美翼状胬肉药物市场区域分析/见解

对北美翼状胬肉药物市场进行了分析，并按国家、疾病类型、阶段、治疗和配方、购买方式、人口类型、最终用户和分销渠道提供了市场规模洞察和趋势。

北美翼状胬肉药物市场报告涵盖的国家包括美国、加拿大和墨西哥。

由于该地区拥有大型市场参与者和成熟的医疗保健体系，北美翼状胬肉药物市场预计将增长。预计美国将在市场份额和市场收入方面主导北美翼状胬肉药物市场。在预测期内，美国将继续保持主导地位。这是由于该地区疾病的患病率很高。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场法规变化。新车和替换车销售、国家人口统计和进出口关税等数据点是预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了北美品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争而面临的挑战以及销售渠道的影响。

竞争格局和北美翼状胬肉药物市场份额分析

北美翼状胬肉药物市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、欧洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对翼状胬肉药物市场的关注有关。

北美翼状胬肉药物市场的一些主要参与者包括强生服务公司、诺华公司、Akorn Operating Company LLC、博士伦公司、艾伯维公司、Prestige Consumer Healthcare Inc.、Théa Laboratories、Wellona Pharma、拜耳公司、Zydus Group、Amneal Pharmaceuticals LLC、OASIS Medical、爱尔康和参天制药株式会社等。

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、北美与地区以及供应商份额分析。如有进一步询问，请要求分析师致电。

SKU-68696